The accreditors of this session require that you periodically check in to verify that you are still attentive.
Please click the button below to indicate that you are.
Oral abstract session featuring the latest research on Practical Immonuhematology
Learning Objectives:
Evaluate RBC antigen typing discrepancies between micro-array molecular method and serologic antigen typing confirmation.
Detail an investigational reagent capable of effectively and successfully neutralizing therapeutic anti-CD47 interference in patient pretransfusion testing.
Demonstrate an updated flow cytometry assay for the quantitation of erythrocyte D antigen sites.
Describe the first 25 years of the American Rare Donor Program, including the growth in rare donors in the program, the growth in requests for rare blood products, and the ability of the program to fill requests.
Speaker(s):
Chloe
Hutchison,
BS,
National Institutes of Health, Clinical Center, Department of Transfusion Medicine
Margaret
A. Keller,
PhD,
Executive, National Laboratories,
American Red Cross
Jeremy
Jacobs,
MD, MHS,
Special Coagulation Fellow,
Department of Laboratory Medicine, Yale School of Medicine
Robert
Maitta,
MD, PhD,
University Hospitals Cleveland Medical Center
All relevant financial relationships have been mitigated.
By completing the evaluation, you are attesting to watching the presentation in its entirety. A certificate will be immediately provided after submission.